Ten Dijke P - Search Results

1

A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment.

Huynh LK, Hipolito CJ, Ten Dijke P. Huynh LK, et al. Among authors: ten dijke p. Biomolecules. 2019 Nov 17;9(11):743. doi: 10.3390/biom9110743. Biomolecules. 2019. PMID: 31744193 Free PMC article. Review.

2

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.

Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P. Deckers M, et al. Among authors: ten dijke p. Cancer Res. 2006 Feb 15;66(4):2202-9. doi: 10.1158/0008-5472.CAN-05-3560. Cancer Res. 2006. PMID: 16489022

3

ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.

Noda D, Itoh S, Watanabe Y, Inamitsu M, Dennler S, Itoh F, Koike S, Danielpour D, ten Dijke P, Kato M. Noda D, et al. Among authors: ten dijke p. Oncogene. 2006 Sep 14;25(41):5591-600. doi: 10.1038/sj.onc.1209571. Epub 2006 Apr 24. Oncogene. 2006. PMID: 16636667

4

Negative regulation of TGF-beta receptor/Smad signal transduction.

Itoh S, ten Dijke P. Itoh S, et al. Among authors: ten dijke p. Curr Opin Cell Biol. 2007 Apr;19(2):176-84. doi: 10.1016/j.ceb.2007.02.015. Epub 2007 Feb 20. Curr Opin Cell Biol. 2007. PMID: 17317136 Review.

5

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.

Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G. Buijs JT, et al. Among authors: ten dijke p. Cancer Res. 2007 Sep 15;67(18):8742-51. doi: 10.1158/0008-5472.CAN-06-2490. Cancer Res. 2007. PMID: 17875715 Free article.

6

Extracellular control of TGFbeta signalling in vascular development and disease.

ten Dijke P, Arthur HM. ten Dijke P, et al. Nat Rev Mol Cell Biol. 2007 Nov;8(11):857-69. doi: 10.1038/nrm2262. Nat Rev Mol Cell Biol. 2007. PMID: 17895899 Review.

7

TGF-beta and BMP7 interactions in tumour progression and bone metastasis.

Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, ten Dijke P, van der Pluijm G. Buijs JT, et al. Among authors: ten dijke p. Clin Exp Metastasis. 2007;24(8):609-17. doi: 10.1007/s10585-007-9118-2. Epub 2007 Nov 16. Clin Exp Metastasis. 2007. PMID: 18008174 Review.

8

Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.

Petersen M, Thorikay M, Deckers M, van Dinther M, Grygielko ET, Gellibert F, de Gouville AC, Huet S, ten Dijke P, Laping NJ. Petersen M, et al. Among authors: ten dijke p. Kidney Int. 2008 Mar;73(6):705-15. doi: 10.1038/sj.ki.5002717. Epub 2007 Dec 12. Kidney Int. 2008. PMID: 18075500 Free article.

9

Role of TGF-beta in the tumor stroma.

Naber HP, ten Dijke P, Pardali E. Naber HP, et al. Among authors: ten dijke p. Curr Cancer Drug Targets. 2008 Sep;8(6):466-72. doi: 10.2174/156800908785699342. Curr Cancer Drug Targets. 2008. PMID: 18781893 Review.

10

TGF-beta signaling in vascular biology and dysfunction.

Goumans MJ, Liu Z, ten Dijke P. Goumans MJ, et al. Among authors: ten dijke p. Cell Res. 2009 Jan;19(1):116-27. doi: 10.1038/cr.2008.326. Cell Res. 2009. PMID: 19114994 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page